About

SurePulse develops high-accuracy, wireless vital sign monitoring technology, purpose-built for newborns. Our innovative devices provide rapid and reliable physiological data, empowering clinical teams to make confident decisions during the critical first minutes of life.

With quick application and fast signal acquisition, SurePulse technology supports improved outcomes and more efficient care. Wireless functionality also helps remove physical barriers to parent-infant bonding, and supports Kangaroo Care and family-integrated care

Our flagship product, the SurePulse VS, a wireless heart rate monitoring Cap, holds both CE and FDA regulatory approval.

We’re also advancing the next generation of care with multi-parameter monitoring devices (ECG heart rate, SpO2, and temperature), currently in clinical trials at Nottingham University Hospitals.

Our Mission
To place babies and their families at the heart of neonatal monitoring—supporting better outcomes from birth to home.

Our Vision
A world where baby-centred innovation transforms neonatal outcomes.

”The SurePulse device has potential to be a significant advancement in the way neonatal patients are monitored in a variety of post-delivery circumstances. ”

Peterson et al, 2024

Frontiers in Pediatrics

Frontiers in Pediatrics

SurePulse was born out of a collaboration between the School of Electrical and Electronic Engineering and the Department of Academic Child Health at the University of Nottingham, after researchers realised that vital sign technology being developed within the University could be applied to monitor newborn babies who need help at birth.

Current approaches are insufficiently accurate, reliable or timely which can lead to deviations from International protocols for delivery room care.

Visit the SurePulse story page to find out more.